Protara Therapeutics (TARA) Return on Capital Employed Growth (3y) (2018 - 2026)
Protara Therapeutics (TARA) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Protara Therapeutics |
216.35 Mn |
216.35 Mn |
- |
2,720.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
2,720.00 |
| Dec 31, 2025 |
1,471.00 |
| Sep 30, 2025 |
-1,687.00 |
| Jun 30, 2025 |
-1,116.00 |
| Mar 31, 2025 |
-332.00 |
| Dec 31, 2024 |
-1,121.00 |
| Sep 30, 2024 |
-2,594.00 |
| Jun 30, 2024 |
-3,264.00 |
| Mar 31, 2024 |
-4,774.00 |
| Dec 31, 2023 |
-3,884.00 |
| Sep 30, 2023 |
-6,275.00 |
| Jun 30, 2023 |
-3,710.00 |
| Mar 31, 2023 |
-1,009.00 |
| Dec 31, 2022 |
32,207.00 |
| Sep 30, 2022 |
8,467.00 |
| Jun 30, 2022 |
7,266.00 |
| Mar 31, 2022 |
7,325.00 |
| Sep 30, 2021 |
8,726.00 |
| Jun 30, 2021 |
7,262.00 |
| Mar 31, 2021 |
7,716.00 |
